HeartCore Enterprises, Inc.

HeartCore Enterprises, Inc. divested its 51% majority ownership in Sigmaways, Inc. and $2.19 million in related debt to Semaphore Technologies, Inc. for up to $650,000. The deal includes a $1,000 cash payment and an earn-out of up to $649,000 based on Sigmaways' future revenue. HeartCore also contributed a $350,000 SAFE Note from Heart-Tech Health as part of the agreement. This strategic divestiture aims to optimize HeartCore's portfolio, reduce exposure to a loss-making subsidiary, and focus on core growth initiatives like Go IPO consulting and financial services.

HeartCore Enterprises reported a significant decline in revenue for the first quarter of 2026, falling to $1.25 million from $2.09 million in the prior year. While the net loss attributable to common shareholders improved to $(1.90) million from $(3.09) million, the company's loss from continuing operations worsened. The company also disclosed substantial doubt about its ability to continue as a going concern due to a net loss from continuing operations of $2.0 million and $1.2 million in cash used in operating activities. A 1-for-20 reverse stock split was effected on April 2, 2026.

HeartCore Enterprises reported first-quarter 2026 financial results with revenues decreasing to $1.2 million from $2.1 million in the prior year. The company's net loss improved to $2.0 million, down from $3.1 million, primarily due to a reduction in the loss on fair value of investments. Operationally, HeartCore regained Nasdaq's minimum bid price requirement and authorized a $2.0 million share repurchase program, while also advancing its strategic focus on financial services and capital markets.

HeartCore Enterprises reported Q1 2026 financial results with revenues decreasing to $1.2 million from $2.1 million year-over-year, primarily due to intense competition in customized software development. Despite this, net loss improved to $2.0 million from $3.1 million, mainly due to a reduction in the loss on the fair value of investments. The company also authorized a $2.0 million share repurchase program and regained Nasdaq's $1.00 minimum bid price requirement, while advancing its strategic focus on financial services and capital markets through its Higgs Field subsidiary.

HeartCore Enterprises, Inc. announced that it has regained compliance with The Nasdaq Stock Market's minimum bid price requirement. The company received written notice on April 22, 2026, confirming that it met the $1.00 minimum bid price rule for continued listing. This positive development ensures the company's common stock will continue to be listed and traded on the Nasdaq Capital Market, resolving a previous non-compliance notice issued on May 6, 2025.